Development of Cost-Effective and Customizable Training and Education Platforms for AD/ADRD Caregivers that Focus on Addressing Financial Management and Legal Planning (R43/R44 Clinical Trial Not Allowed)

0
148

Funding Opportunity ID: 327360
Opportunity Number: RFA-AG-21-025
Opportunity Title: Development of Cost-Effective and Customizable Training and Education Platforms for AD/ADRD Caregivers that Focus on Addressing Financial Management and Legal Planning (R43/R44 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.866
Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: May 27, 2020
Close Date: Nov 12, 2020
Last Updated Date: May 27, 2020
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding: $4,800,000
Expected Number of Awards: 6
Description: This Small Business (R43/R44) Funding Opportunity Announcement (FOA) seeks to encourage small business research and development (R and D) of tools and technologies to support individuals, families, and care partners of individuals with Alzheimer's disease (AD) and AD-related dementias (ADRD) in dealing with financial and estate-related activities and responsibilities, which are often challenging and expensive to address and manage successfully. Tools and technologies designed in response to this FOA should be accessible to and appropriate for use by diverse populations across the socioeconomic spectrum.
Version: 1





Visit the Official Webpage For More Details on Development of Cost-Effective and Customizable Training and Education Platforms for AD/ADRD Caregivers that Focus on Addressing Financial Management and Legal Planning (R43/R44 Clinical Trial Not Allowed)